| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000014392 |
| Receipt No. | R000015699 |
| Official scientific title of the study | The efficacy and safety of a hypertonic polyethylene glycol - electrolyte lavage solution (PEG-ELS) for patients with constipated patients or regularly user of a laxative: a randomized study |
| Date of disclosure of the study information | 2014/06/26 |
| Last modified on | 2016/11/10 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | The efficacy and safety of a hypertonic polyethylene glycol - electrolyte lavage solution (PEG-ELS) for patients with constipated patients or regularly user of a laxative: a randomized study | |
| Title of the study (Brief title) | The efficacy and safety of a hypertonic polyethylene glycol - electrolyte lavage solution (PEG-ELS). | |
| Region |
|
|
| Condition | ||
| Condition | Patients with chronic constipation, functional constipation or regularly use of a laxative | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To assess the efficacy and safety of a hypertonic PEG-ELS for patients with constipated patients or regularly user of a laxative compared with a conventional PEG-ELS. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | The rate of poor colon preparation(Ottawa bowel preparation scale>2) and rate of the patients who needed the enema . |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Open -but assessor(s) are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | Institution is not considered as adjustment factor. |
| Blocking | NO |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | A hypertonic PEG-ELS is administrated for colonoscopy bowel preparation. | |
| Interventions/Control_2 | A conventional PEG-ELS is administrated for colonoscopy bowel preparation. | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1)Patients with chronic constipation or functional constipation.
(2) 20years or older and up to 80 years old. (3) Patients judged to resect polyp in total colonoscopy within the past two years, and undergoing polypectomy. (4) )Written informed consent obtained. |
|||
| Key exclusion criteria | (1) Patients with a history of gastrointestinal tractresection (excluding appendicectomy)
(2) Patients required for colonic ESD (3) Patients who may have ileus (4) Patients who have a history of perforation and may have perforation of gastrointestinal tract (5) Patients with failure of gastric empty (6) Patients with toxic megacolon (7) Patients with a history of hypersensitivity to composition of a PEG-ELS or Moviprep (8) Patients with nausea and vomiting (9) Patients who request to increase dose of a laxative which is taken commonly from obtaining informed consent to the day before preparation (10)Patients who may be admitted for purposes of other than polypectomy (11) Patients who are considered to be unsuitable by the trial investigators |
|||
| Target sample size | 100 | |||
| Research contact person | |
| Name of lead principal investigator | Mototsugu Kato |
| Organization | Hokkaido University Hospital |
| Division name | Division of Endoscopy |
| Address | North 14, West 5, Kita-Ku, Sapporo, Hokkaido, Japan |
| TEL | +81-11-716-1161 |
| m-kato@med.hokudai.ac.jp | |
| Public contact | |
| Name of contact person | Katsuhiro Mabe |
| Organization | Hokkaido University Hospital |
| Division name | Division of Endoscopy |
| Address | Kita14,Nishi5,Kita-ku,Sapporo |
| TEL | +81-11-716-1161 |
| Homepage URL | |
| kmabe@med.hokudai.ac.jp | |
| Sponsor | |
| Institute | Hokkaido University Hospital, Division of Endoscopy |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hokkaido University Hospital, Division of Endoscopy |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000015699 |